BioSpace News Archive

Career Advice

Career Coach: How to Overcome the Fears and Pitfalls of Networking in 2024

Carina Clingman answers questions about forging professional connections in-person and on LinkedIn.

January 11, 2024
·
7 min read
·
Carina Clingman
Business

Q&A: Takeda’s Elena Koundourakis Talks Orexin Program Ahead of Expected Readout

Speaking to BioSpace in San Francisco, Elena Koundourakis, the head of the orexin franchise at Takeda Pharmaceuticals, gave a preview of what is ahead for its aims to treat narcolepsy.

January 11, 2024
·
2 min read
·
Tyler Patchen
Job Trends

The Top 5 Companies Hiring Analysts

Analysts in life sciences play a crucial role in analyzing and interpreting data to support research, development and decision-making processes within the field.

January 11, 2024
·
1 min read
·
Editorial Staff
Policy

JPM2024: IRA Favors Biologics Over Small Molecule Drugs and Hurts Innovation, Industry Analysts Say

Biologics have a major advantage over small molecule drugs under the Inflation Reduction Act’s provisions, according to stakeholders attending this week’s J.P. Morgan conference.

January 11, 2024
·
3 min read
·
Greg Slabodkin
JPM2024: Cancer Biotech Executives Look Ahead to the Coming Year

A lot of attention at JPM was focused on the cancer space. Executives from Olema Oncology and Cyclacel spoke with BioSpace about their plans for 2024 and why biotech’s kickoff conference is important to them.

January 11, 2024
·
2 min read
·
Tyler Patchen
DSM-5 Panel Members Received $14.2M in Industry Funding: Study

A new study published in the BMJ found strong financial ties between the pharmaceutical industry and physicians serving as panelists and task force members of the DSM-5.

January 11, 2024
·
2 min read
·
Tristan Manalac
Deals

‘Let The Good Times Roll Again’: VCs Confident in Biotech Activity for ’24

Panelists at JPM’s Biotech Showcase gave positive projections as the year begins and offered advice to those in the space.

January 11, 2024
·
2 min read
·
Tyler Patchen
Business

BioNTech Continues to Build Pipeline with First Deal of 2024

The German biotech is dropping $20 million upfront on two preclinical monoclonal antibodies for undisclosed targets developed by WuXi Biologics.

January 11, 2024
·
2 min read
·
Kate Goodwin
Job Trends

2023 Q4 Job Market Report: Competition for Jobs Intensifies

If it feels like there has never been a tougher time to look for work, you’re not alone—and you’re likely not wrong.

January 11, 2024
·
1 min read
·
Chantal Dresner
Avance Clinical: Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner Affecting Drug Development Schedules and Financial Plans

Avance Clinical, the leading Australian CRO for biotechs, announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program.

January 11, 2024
·
3 min read